Newsletters and Deep Dive digital magazine
Shares in Minerva Neurosciences have lost more than half their value after the FDA rejected its marketing application for roluperidone as a treatment for the negative symp
The UK is welcoming a new era of clinical trial delivery, evolving beyond the traditional site-centric approach to also embrace remote, decentralised, virtual, and hybrid trials and enablin
Artificial intelligence (AI) has become an omnipresent force in our lives. From our homes to workplaces, from healthcare to entertainment, AI has permeated every facet of modern existence.
Medical Affairs is consolidating its position as a critical pillar of commercial and reputational success and it is expected to play an increasingly important role as digital continues to r
In June, pharmaphorum came together with the Connected World Without Disease Accelerator for the inaugural World Without Disease Summit, a two-day event that brought together stakeholders f
A brand-new event has just launched in the renowned World ADC Series – the inaugural ADC Payload Summit is taking place
The industry has been calling for a disease-agnostic event fully dedicated to the exciting new modality of peptide-based drugs.
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox
The Peterson Health Technology Institute (PHTI) has added hypertension and mental health to the list of digital health technologies (DHTs) that it will review for their cl
Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment